In recent years, research on molecular mutations in non-small cell lung cancer (NSCLC) has increased our knowledge of biological pathways driving tumor development; the identification of mutations within the epidermal growth factor receptor (EGFR) gene is one such example [11]. Here, EGFR is linked to non-small cell lung carcinoma.